FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
11,723 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Asparagus Officinalis | Asparagus 1 [hp_M]/1 | PelletOral | Hahnemann Laboratories, Inc. | Unapproved homeopathic | 63545-281 | 63545-0281-0163545-0281-0263545-0281-03+1 more | — |
| asparlascalaspargase pegol | Calaspargase pegol 750 U/mL | Injection, SolutionIntravenous | Servier Pharmaceuticals LLC | BLA | 72694-515 | 72694-0515-01 | — |
| Aspartame/MSG Detoxchelidonium majus, arnica montana, phytolacca decandra, nitricum acidum, nux vomica, phosphoricum acidum, bisphenol a (bpa), dextrose, maltodextrin, sucralose, aspartic acid, diketopiperazine, dopamine hydrochloride, formalinum, formicum acidum, l-phenylalanine, methyl alcohol, monosodium glutamate | Chelidonium majus whole 3 [hp_X]/mL + 17 more ingredients |
| LiquidOral |
| Deseret Biologicals, Inc. |
| Unapproved homeopathic |
| 43742-1252 |
| 43742-1252-01 |
| — |
| Aspen Glow 100% Mineral Broad Spectrum SPF 30 Powder Sunscreen 0.16 oz / 4.6 gzinc oxide | Zinc oxide 24.9 g/100g | PowderTopical | Aspen Glow Cosmetics, LLC | OTC monograph drug | 83512-0008 | 83512-0008-00 | — |
|---|
| Aspen Islanders Sheer Mineral Sportzinc oxide | Zinc oxide 132 mg/mL | LotionTopical | Aspen Islanders LLC | OTC monograph drug | 83382-1005 | 83382-1005-02 | — |
|---|
| Aspen Pollenpopulus tremuloides | Populus tremuloides pollen .1 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1430 | 22840-1430-0222840-1430-04 | — |
|---|
| Aspen Pollenpopulus tremuloides | Populus tremuloides pollen .001 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1431 | 22840-1431-01 | — |
|---|
| Aspen Pollenpopulus tremuloides | Populus tremuloides pollen 20000 [PNU]/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-4431 | 22840-4431-02 | — |
|---|
| Aspen Pollenpopulus tremuloides | Populus tremuloides pollen .05 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-4432 | 22840-4432-02 | — |
|---|
| Aspen Pollenpopulus tremuloides | Populus tremuloides pollen .05 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-5408 | 22840-5408-0222840-5408-0422840-5408-05 | — |
|---|
| Aspen Pollenpopulus tremuloides | Populus tremuloides pollen .05 g/mL | InjectionCutaneous, Intradermal, Subcutaneous | Allermed Laboratories, Inc. | BLA | 49643-398 | 49643-0398-0549643-0398-1049643-0398-30+1 more | — |
|---|
| Asper Flexlidocaine | Lidocaine 4 g/100g | CreamTopical | Akron Pharma Inc. | OTC monograph drug | 71399-0049 | 71399-0049-0171399-0049-0271399-0049-03 | — |
|---|
| Aspercremelidocaine | Lidocaine 246 mg/1 | PatchTopical | Lead Chemical Co. Ltd. | OTC monograph drug | 62168-0584 | 62168-0584-0562168-0584-06 | — |
|---|
| Aspercreme Arthritisdiclofenac sodium | Diclofenac sodium .01 g/g | GelTopical | Chattem, Inc. | ANDA | 41167-0571 | 41167-0571-0041167-0571-01 | — |
|---|
| Aspercreme Arthritisdiclofenac sodium | Diclofenac sodium .01 g/g | GelTopical | Chattem, Inc. | ANDA | 41167-0573 | 41167-0573-0241167-0573-03 | — |
|---|
| Aspercreme Lidocaine Foot (Diabetic)lidocaine hydrochloride | Lidocaine hydrochloride 4 g/100g | CreamTopical | Chattem, Inc. | OTC monograph drug | 41167-0597 | 41167-0597-00 | — |
|---|
| Aspercreme Lidocaine No-Mess plus Lavenderlidocaine hcl | Lidocaine hydrochloride 4 g/100mL | LiquidTopical | Chattem, Inc. | OTC monograph drug | 41167-0568 | 41167-0568-0541167-0568-06 | — |
|---|
| Aspercreme Lidocaine with Eucalyptus Essential Oillidocaine hcl | Lidocaine hydrochloride 4 g/100g | CreamTopical | Chattem, Inc. | OTC monograph drug | 41167-0566 | 41167-0566-00 | — |
|---|
| Aspercreme Lidocaine with Rosemary and Mintlidocaine hydrochloride | Lidocaine hydrochloride 4 g/100g | CreamTopical | Chattem, Inc. | OTC monograph drug | 41167-0565 | 41167-0565-00 | — |
|---|
| Aspercreme Lidocaine XLlidocaine | Lidocaine 411.4 mg/1 | PatchTopical | Lead Chemical Co., Ltd. | OTC monograph drug | 62168-0585 | 62168-0585-02 | — |
|---|
| Aspercreme Pain Relievingtrolamine salicylate | Trolamine salicylate 10 g/100g | CreamTopical | Chattem, Inc. | OTC monograph drug | 41167-0570 | 41167-0570-0341167-0570-05 | — |
|---|
| Aspercreme Professional Creamlidocaine hcl 4% | Lidocaine HCl 4 g/100g | CreamTopical | Chattem, Inc. | OTC monograph drug | 41167-0564 | 41167-0564-0041167-0564-0141167-0564-03 | — |
|---|
| Aspercreme with Lidocainelidocaine | Lidocaine 4 g/100g | PatchTopical | Chattem, Inc. | OTC monograph drug | 41167-0584 | 41167-0584-0041167-0584-0341167-0584-07 | — |
|---|
| Aspercreme with Lidocaine Drylidocaine | Lidocaine 4 g/100mL | SprayTopical | Chattem, Inc. | OTC monograph drug | 41167-0583 | 41167-0583-05 | — |
|---|
| Aspercreme with Lidocaine Essential Oils Rosemary Mintlidocaine | Lidocaine 4 g/100mL | LiquidTopical | Chattem, Inc. | OTC monograph drug | 41167-0598 | 41167-0598-07 | — |
|---|
| Aspercreme with Lidocaine Foot Pain Cremelidocaine hydrochloride | Lidocaine hydrochloride 4 g/100g | CreamTopical | Chattem, Inc. | OTC monograph drug | 41167-0586 | 41167-0586-02 | — |
|---|
| Aspercreme with Lidocaine No-Mess Applicatorlidocaine hydrochloride | Lidocaine hydrochloride 4 g/100mL | LiquidTopical | Chattem, Inc. | OTC monograph drug | 41167-0581 | 41167-0581-0041167-0581-05 | — |
|---|
| Aspercreme with lidocaine No-Mess Applicator Two Packlidocaine hydrochloride | Lidocaine hydrochloride 4 g/100mL | LiquidTopical | Chattem, Inc. | OTC monograph drug | 41167-0599 | 41167-0599-09 | — |
|---|
| Aspercreme with Lidocaine Pain Relieving Cremelidocaine hydrochloride | Lidocaine hydrochloride 4 g/100g | LotionTopical | Chattem, Inc. | OTC monograph drug | 41167-0582 | 41167-0582-01 | — |
|---|
| Aspercreme with Lidocaine Pain Relieving Cremelidocaine hydrochloride | Lidocaine hydrochloride 4 g/100g | LotionTopical | Chattem, Inc. | OTC monograph drug | 41167-0587 | 41167-0587-0741167-0587-08 | — |
|---|
| Aspercreme with Lidocaine XLlidocaine | Lidocaine 422 mg/1 | PatchTopical | Chattem, Inc. | OTC monograph drug | 41167-0585 | 41167-0585-0041167-0585-02 | — |
|---|
| AsperFlexlidocaine | Lidocaine 4 g/100g | PatchTopical | Akron Pharma Inc. | OTC monograph drug | 71399-4456 | 71399-4456-0371399-4456-05 | — |
|---|
| AsperFlexmenthol and methyl salicylate | Menthol 100 mg/g; Methyl salicylate 150 mg/g | CreamTopical | Akron Pharma Inc. | OTC monograph drug | 71399-6854 | 71399-6854-03 | — |
|---|
| AsperFlex Advancecamphor, menthol, methyl salicylate | Camphor (Synthetic) 86.24 mg/1 + 2 more ingredients | PatchPercutaneous, Topical, Transdermal | Akron Pharma Inc. | OTC monograph drug | 71399-4458 | 71399-4458-06 | — |
|---|
| AsperFlex HOTcamphor, menthol, methyl salicylate | Capsicum .025 g/100g; Menthol 1.25 g/100g | PatchPercutaneous, Topical, Transdermal | Akron Pharma Inc. | OTC monograph drug | 71399-4439 | 71399-4439-06 | — |
|---|
| AsperFlex MAXlidocaine 4% with menthol 1% | Lidocaine 240 mg/1; Menthol 60 mg/1 | PatchTopical | Akron Pharma Inc. | OTC monograph drug | 71399-4453 | 71399-4453-05 | — |
|---|
| AsperFlex Original Maximum Strengthmenthol | Menthol 210 mg/1 | PatchTopical | Akron Pharma Inc. | OTC monograph drug | 71399-4461 | 71399-4461-05 | — |
|---|
| Aspergillus amstelodami | Eurotium amstelodami .001 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1608 | 22840-1608-01 | — |
|---|
| Aspergillus amstelodami | Eurotium amstelodami 1000 [PNU]/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1609 | 22840-1609-01 | — |
|---|
| Aspergillus amstelodami | Eurotium amstelodami .05 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-5602 | 22840-5602-0222840-5602-0422840-5602-05 | — |
|---|
| Aspergillus flavus | Aspergillus flavus .05 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1610 | 22840-1610-0222840-1610-04 | — |
|---|
| Aspergillus flavus | Aspergillus flavus .001 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1612 | 22840-1612-01 | — |
|---|
| Aspergillus flavus | Aspergillus flavus 40000 [PNU]/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1614 | 22840-1614-04 | — |
|---|
| Aspergillus flavus | Aspergillus flavus .025 [PNU]/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-5603 | 22840-5603-0222840-5603-0422840-5603-05 | — |
|---|
| Aspergillus Fumigatus | Aspergillus fumigatus .1 g/mL | Injection, SolutionSubcutaneous | ALK-Abello, Inc. | BLA | 0268-8084 | 00268-8084-1000268-8084-50 | — |
|---|
| Aspergillus Fumigatus | Aspergillus fumigatus .05 g/mL | Injection, SolutionPercutaneous | ALK-Abello, Inc. | BLA | 0268-8085 | 00268-8085-05 | — |
|---|
| Aspergillus fumigatus | Aspergillus fumigatus .1 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1615 | 22840-1615-0222840-1615-04 | — |
|---|
| Aspergillus fumigatus | Aspergillus fumigatus 20000 [PNU]/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1616 | 22840-1616-02 | — |
|---|
| Aspergillus fumigatus | Aspergillus fumigatus 40000 [PNU]/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1617 | 22840-1617-0222840-1617-04 | — |
|---|
| Aspergillus fumigatus | Aspergillus fumigatus .05 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1618 | 22840-1618-0222840-1618-04 | — |
|---|